PHILADELPHIA The American Association for Cancer Research expresses its congratulations to and appreciation of William S. Dalton, M.D., Ph.D., who will receive the 2010 Leadership in Personalized Medicine Award from the Personalized Medicine Coalition (PMC).
Dalton, who has been a distinguished member of the AACR for more than 20 years, will receive the award from the PMC at the Harvard Personalized Medicine Conference on Nov. 17. According to the PMC, he is recognized for "his pioneering work putting the concepts of personalized medicine into practice for the benefit of patients."
Dalton is the chief executive officer of the H. Lee Moffitt Cancer Center in Tampa, Fla. He also serves as chair of the AACR's Science Policy and Legislative Affairs Committee.
"This is a wonderful and fitting honor for Dr. Dalton, who is at the forefront of personalized medicine and whose work has benefitted countless cancer patients," said Margaret Foti, Ph.D., M.D. (h.c.), chief executive officer of the AACR. "Moreover, Dr. Dalton's contributions extend beyond the lab and clinic to the halls of Congress. As chair of the AACR's Science Policy and Legislative Affairs Committee, he convenes the committee that guides the AACR's policy efforts. Dr. Dalton is a leader who is impacting the field on many levels, and we celebrate his achievement."
Dalton received his doctoral degree in toxicology and medical life sciences and his medical degree from Indiana University. He completed his internship in internal medicine at Indiana University, his residency in medicine at the University of Arizona in Tucson and his fellowships in oncology and clinical pharmacology at the University of Arizona. He is board certified in internal medicine and medical oncology and is an expert in multiple myeloma.
The PMC Award recognizes an individual whose contributions in science, business and/or policy have helped advance the frontiers of personalized medicine
|Contact: Rachael Cullins|
American Association for Cancer Research